Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine (Q44438134)

3 December 2017

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine (English)

1 reference

3 December 2017

Plasmodium falciparum

0 references

0 references

1 reference

14

W Ripley Ballou

1 reference

3 December 2017

9

Marie-Claude Dubois

1 reference

3 December 2017

Christian F Ockenhouse

5

object named as

Christian F Ockenhouse

1 reference

3 December 2017

1

Evelina Angov

1 reference

3 December 2017

13

D Gray Heppner

1 reference

3 December 2017

12

Kenneth H Eckels

1 reference

3 December 2017

Kent E Kester

6

1 reference

ORCID Public Data File 2021

Carter L Diggs

15

object named as

Carter L Diggs

1 reference

3 December 2017

Barbara M Aufiero

2

1 reference

3 December 2017

Ann Marie Turgeon

3

1 reference

3 December 2017

Michel Van Handenhove

4

1 reference

3 December 2017

Douglas S Walsh

7

1 reference

3 December 2017

Jana S McBride

8

1 reference

3 December 2017

Joe Cohen

10

1 reference

3 December 2017

J David Haynes

11

1 reference

3 December 2017

Jeffrey A Lyon

16

1 reference

3 December 2017

language of work or name

1 reference

1 May 2003

1 reference

Molecular and Biochemical Parasitology

3 December 2017

1 reference

3 December 2017

128

1 reference

3 December 2017

2

1 reference

3 December 2017

195-204

1 reference

Gamma-globulin and acquired immunity to human malaria.

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

The major merozoite surface protein as a malaria vaccine target

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Protective antigens of rodent and human bloodstage malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Processing of the precursor to the major merozoite surface antigens of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Plasmodium yoelii yoelii 17XL MSP-1: fine-specificity mapping of a discontinuous, disulfide-dependent epitope recognized by a protective monoclonal antibody using expression PCR (E-PCR)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Proteins on the surface of the malaria parasite and cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Immunization against malaria with a recombinant protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Passive transfer of growth-inhibitory antibodies raised against yeast-expressed recombinant Plasmodium falciparum merozoite surface protein-1(19).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Different regions of the malaria merozoite surface protein 1 of Plasmodium chabaudi elicit distinct T-cell and antibody isotype responses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Antigens of the erythrocytic stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Plasmodium falciparum: gene structure and hydropathy profile of the major merozoite surface antigen (gp195) of the Uganda-Palo Alto isolate

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Purification of Plasmodium falciparum merozoites for analysis of the processing of merozoite surface protein-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900077-X

7 January 2021

10.1016/S0166-6851(03)00077-X

Identifiers

DOI

1 reference

3 December 2017

1 reference